Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2025)

ARS Pharmaceuticals (SPRY) has disclosed Inventory Average for 2 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 172.5% to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 172.5% year-over-year, with the annual reading at $6.8 million for FY2025, N/A changed from the prior year.
  • Inventory Average hit $8.1 million in Q4 2025 for ARS Pharmaceuticals, down from $8.3 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $8.3 million in Q3 2025 to a low of $3.0 million in Q4 2024.